NEW YORK (Reuters Health) - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests. For children with urinary incontinence, the first approach to treatment is usually behavior modification - sometimes called bladder training or "urotherapy." Tactics like changing drinking habits and taking scheduled trips ...More
WASHINGTON (Reuters) - A biotechnology company's genetically engineered salmon are as safe to eat as other Atlantic salmon, U.S. regulators said as they weighed approval of the first DNA-altered animal for Americans' dinner plates. The AquAdvantage salmon, developed by Aqua Bounty Technologies Inc, are genetically modified to grow twice ...More
NEW YORK (Reuters Health) - Older adults who have a colonoscopy performed by a family doctor, internist or general surgeon are somewhat more likely to need another one within a year compared with those who have the procedure done by a gastroenterologist, a new report finds. The study, based on Medicare ...More
NEW YORK (Reuters Health) - Efforts to adopt a more accurate test for diagnosing diabetes may have hit a snag. Comparing the age-old oral glucose tolerance test to the newer hemoglobin A1c test confirms earlier evidence that race may influence test results, Danish researchers report. "The prevalence of diabetes differed considerably ...More
Corrects spelling of Gleevec in 12th paragraph SILVER SPRING, Maryland (Reuters) - It wasn't what you would call a casual get-together. In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol ...More
WASHINGTON (Reuters) - An estimated five million uninsured children in the United States were eligible for Medicaid or the Childrens Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report. The study published on Friday in the journal "Health Affairs" recommended policy reforms and broader ...More
LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday. Researchers who conducted the work said the results were worrying, but should ...More
